# Sorcero

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sorcero

- Industry: Software
- Headquarters: Washington, US
- Website: www.sorcero.com
- Total disclosed funding: $56M
- Latest round: Series B (Nov 21, 2025)
- Investors on record: 10

## About

Sorcero, Inc. specializes in advanced data analytics and AI-driven solutions for Medical Affairs and Pharmacovigilance teams, enhancing their operational efficiency through innovative technologies. Founded in 2017, Sorcero, Inc. is based in Washington, US, and focuses on leveraging AI to improve healthcare data analysis. In November 2025, Sorcero, Inc. raised USD 42.5 million in series B funding led by new investor NewSpring, with participation from other new investors First Trust Capital Management and Blu Venture Investors. Returning investor Leawood Venture Capital also participated in the round. The leadership team includes CEO Dipanwita Das, alongside co-founders Richard Graves and Walter Bender, who bring extensive experience in their respective fields. Sorcero offers an advanced suite of products designed to empower Medical Affairs and Pharmacovigilance teams through enhanced data analytics and AI capabilities. Central to their product line is the Sorcero Intelligence Platform, which features the Sorcero Instant Insights Engine—launched in 2025. This engine utilizes AI to analyze medical themes, notes, and conversational data, providing high-quality, accessible answers to complex medical inquiries, thus transforming disparate medical data into actionable insights. Sorcero's solutions aim to streamline processes such as literature surveillance, safety signal detection, and scientific communication, improving the efficiency of healthcare stakeholders. The company serves a diverse client base, including pharmaceutical companies, biotechnology firms, and healthcare organizations, primarily within North America and Europe.Sorcero generates revenue through subscription-based models and partnerships with key players in the healthcare and life sciences sectors. These transactions typically involve annual or multi-year contracts where clients gain access to the Sorcero Intelligence Platform and its various functionalities, including Medical Insights Management and Intelligent Publication Monitoring. Such agreements allow clients to integrate Sorcero’s AI-driven services into their existing workflows, enhancing their capacity to generate evidence and insights. Pricing plans are structured to accommodate different levels of service and usage, depending on the specific needs of the clients. The company plans to utilize the November 2025 funding to expand globally across medical segments and further scale its medical-insights platform.

## Funding rounds

- Series B, Nov 21, 2025, $43M — NewSpring, Blu Venture Investors, Leawood Venture Capital, First Trust Capital Management
- Series A, Jul 9, 2021, $10M — Alumni Ventures Group, WorldQuant Ventures, Leawood Venture Capital, Mighty Capital, H/L Ventures, Harmonix, Rackhouse Venture Capital
- Series A, Jun 16, 2020, $3.5M — WorldQuant Ventures, Leawood Venture Capital

## Investors

- WorldQuant Ventures (https://capitalatlas.ai/funds/worldquant-ventures) — Series A
- Leawood Venture Capital (https://capitalatlas.ai/funds/leawood-venture-capital) — Series A, Series B
- Alumni Ventures Group (https://capitalatlas.ai/funds/alumni-ventures-group) — Series A
- Mighty Capital (https://capitalatlas.ai/funds/mighty-capital) — Series A
- H/L Ventures (https://capitalatlas.ai/funds/h-l-ventures) — Series A
- Harmonix — Series A
- Rackhouse Venture Capital (https://capitalatlas.ai/funds/rackhouse-venture-capital) — Series A
- NewSpring (https://capitalatlas.ai/funds/newspring) — Series B
- Blu Venture Investors (https://capitalatlas.ai/funds/blu-venture-investors) — Series B
- First Trust Capital Management — Series B